Patents by Inventor Hyun Sun Lee

Hyun Sun Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240136267
    Abstract: A semiconductor package according to an embodiment includes a first insulating layer; and a first through electrode part passing through the first insulating layer and having a shape elongated in a first direction; wherein the first through electrode part includes a plurality of first through electrodes spaced apart from each other in a second direction perpendicular to the first direction and a thickness direction; wherein at least one of the plurality of first through electrodes includes a first sub through electrode and a second sub through electrode spaced apart from each other in the first direction; and wherein at least one of the first sub through electrode and the second sub through electrode has a width in the first direction greater than a width in the second direction.
    Type: Application
    Filed: February 17, 2022
    Publication date: April 25, 2024
    Applicant: LG INNOTEK CO., LTD.
    Inventors: Hyun Sun LEE, Dae Sung MOON, Dong Hun JOUNG
  • Publication number: 20240135371
    Abstract: Disclosed are a method and apparatus for providing an instant messaging service associated with one or more item transactions. A first user interface screen associated with an item transaction may be provided in a chatroom interface of an executed messenger application. The first user interface screen may comprise an interfacing object associated with a list of user interface templates. Based on a user selection of the interface object and based at least one exposure condition associated with the list of user interface templates, at least one user interface template may be selected from the list of user interface templates for display in a second user interface screen of the executed messenger application. In a second user interface screen of the executed messenger application, a first user interface template of the at least one user interface template may be displayed.
    Type: Application
    Filed: October 15, 2023
    Publication date: April 25, 2024
    Applicant: KAKAO CORP.
    Inventors: Sang Kyeong Lee, Seo Ji Lee, Lim Ah Lee, Yoon Sun Lee, Hyun Ji Oh, Je Woo Song
  • Publication number: 20240097296
    Abstract: The present invention relates to a secondary battery in which a first region and a second region of an insulation sheet are made of different materials, and thus thermal conduction between an electrode assembly and a cap plate can be blocked, light reflection that may occur during welding can be prevented, and the presence of checking foreign matter can be checked through vision inspection.
    Type: Application
    Filed: May 3, 2022
    Publication date: March 21, 2024
    Inventors: Min Hyung GUEN, Hyun Soo LEE, Jun Sun YONG
  • Publication number: 20240086603
    Abstract: A method of reinforcement learning of a neural network device for generating a verification vector for verifying a circuit design comprising a circuit block includes inputting a test vector to the circuit block, generating one or more rewards based on a coverage corresponding to the test vector, the coverage being determined based on a state transition of the circuit block based on the test vector, and applying the one or more rewards to a reinforcement learning.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 14, 2024
    Applicant: SAMSUNG ELECTRONICS CO, LTD.
    Inventors: In HUH, Jeong-hoon KO, Hyo-jin CHOI, Seung-ju KIM, Chang-wook JEONG, Joon-wan CHAI, Kwang-II PARK, Youn-sik PARK, Hyun-sun PARK, Young-min OH, Jun-haeng LEE, Tae-ho LEE
  • Publication number: 20240072314
    Abstract: A gas suppression device for a lithium-sulfur battery includes a voltage measurement unit to measure a voltage of the lithium-sulfur battery; a current application unit to apply an electric current; and a control unit configured to control the current application unit to maintain the voltage of the lithium-sulfur battery within a predetermined range based on a voltage measurement result of the voltage measurement unit, to suppress gas generation in the lithium-sulfur battery having gone through an activation step.
    Type: Application
    Filed: August 30, 2023
    Publication date: February 29, 2024
    Inventors: Min-Sun SONG, Hyun-Soo LEE
  • Patent number: 11917873
    Abstract: A display device includes a substrate having a pixel area and a peripheral area, a plurality of pixels disposed on the substrate in the pixel area, a plurality of data lines that supply a plurality of data signals to the pixels, a plurality of scan lines that supply a plurality of scan signals to the pixels, a plurality of power supply lines that supply a first voltage to the pixels, and first through third insulating layers. The first insulating layer is disposed on the substrate, the second insulating layer is disposed on the first insulating layer, and the third insulating layer is disposed on the second insulating layer. The scan lines are disposed below the third insulating layer on the substrate in the pixel area, and are disposed on the third insulating layer in the peripheral area.
    Type: Grant
    Filed: December 30, 2020
    Date of Patent: February 27, 2024
    Assignee: SAMSUNG DISPLAY CO., LTD.
    Inventors: Byung Sun Kim, Sun Ja Kwon, Yang Wan Kim, Hyun Ae Park, Su Jin Lee, Jae Yong Lee
  • Patent number: 8906952
    Abstract: The present invention relates to an indole derivative, The indole derivative according to the present invention effectively inhibits the activity of diacylglycerol acyltransferase (DGAT) which induces metabolic diseases, such as obesity, diabetes, hyperlipidemia, or fatty liver and the like in lipid metabolism, thereby effectively regulating lipid metabolism and energy metabolism, and thus can be useful in pharmaceutical compositions for preventing or treating metabolic disease.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: December 9, 2014
    Assignee: Korea Research Institute of Bioscience & Biotechnology
    Inventors: Hyun Sun Lee, Mun-Ock Kim, Yongseok Choi, Kyeong Lee, Jeong-Jun Park, Jee-Hee Seo, Hwayoung Jung, Sungchan Cho
  • Publication number: 20140057909
    Abstract: The present invention relates to an indole derivative, The indole derivative according to the present invention effectively inhibits the activity of diacylglycerol acyltransferase (DGAT) which induces metabolic diseases, such as obesity, diabetes, hyperlipidemia, or fatty liver and the like in lipid metabolism, thereby effectively regulating lipid metabolism and energy metabolism, and thus can be useful in pharmaceutical compositions for preventing or treating metabolic disease.
    Type: Application
    Filed: November 4, 2013
    Publication date: February 27, 2014
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyun Sun LEE, Mun-Ock KIM, Yongseok CHOI, Kyeong Lee, Jeong-Jun PARK, Jee-Hee SEO, Hwayoung JUNG, Sungchan CHO
  • Patent number: 8304448
    Abstract: Disclosed is a composition for the prevention and treatment of metabolic diseases, which comprises a benzazole derivative as an active ingredient. The benzazole derivative has inhibitory activity against DGAT (diacylglycerol acyltransferase), which causes metabolic diseases such as obesity and diabetes in the process of lipid metabolism. With the ability to effectively control lipid metabolism and energy metabolism, thus, the composition is useful in the prevention and treatment of metabolic diseases, such as obesity and diabetes.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: November 6, 2012
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyun Sun Lee, Kyeong Lee, Jung Joon Lee, Young Kook Kim, Mun-Chual Rho, Jeong Hyung Lee, Young Soo Hong, Hye-Ran Park, Chul-Ho Lee, Yongseok Choi
  • Patent number: 7902190
    Abstract: Disclosed are indole derivatives, a preparation method thereof, and a composition for the prevention and treatment of metabolic diseases, containing the same as an active ingredient. The indole derivatives have inhibitory activity against DGAT (diacylglycerol acyltransferase), which causes metabolic diseases such as obesity and diabetes in the process of lipid metabolism. With the ability to effectively control lipid metabolism and energy metabolism, the composition is thus useful in the prevention and treatment of metabolic diseases, such as obesity and diabetes.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: March 8, 2011
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Kyeong Lee, Hyun Sun Lee, Jung Joon Lee, Young Kook Kim, Mun-Chual Rho, Jeong Hyung Lee, Hye-Ran Park, Chul-Ho Lee, Yongseok Choi
  • Publication number: 20100075962
    Abstract: Disclosed are indole derivatives a preparation method thereof, and a composition for the prevention and treatment of metabolic diseases, containing the same as an active ingredient. The indole derivatives have inhibitory activity against DGAT (diacylglycerol acyltransferase), which causes metabolic diseases such as obesity and diabetes in the process of lipid metabolism. With the ability to effectively control lipid metabolism and energy metabolism, the composition is thus useful in the prevention and treatment of metabolic diseases, such as obesity and diabetes.
    Type: Application
    Filed: September 27, 2007
    Publication date: March 25, 2010
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Kyeong Lee, Hyun Sun Lee, Jung Joon Lee, Young Kook Kim, Mun-Chual Roh, Jeong Hyung Lee, Hye-Ran Park, Chul-Ho Lee, Yongseok Choi
  • Publication number: 20100076039
    Abstract: Disclosed is a composition for the prevention and treatment of metabolic diseases, which comprises a benzazole derivative as an active ingredient. The benzazole derivative has inhibitory activity against DGAT (diacylglycerol acyltransferase), which causes metabolic diseases such as obesity and diabetes in the process of lipid metabolism. With the ability to effectively control lipid metabolism and energy metabolism, thus, the composition is useful in the prevention and treatment of metabolic diseases, such as obesity and diabetes.
    Type: Application
    Filed: September 27, 2007
    Publication date: March 25, 2010
    Inventors: Hyun Sun Lee, Kyeong Lee, Jung Joon Lee, Young Kook Kim, Mun-Chual Rho, Jeong Hyung Lee, Young Soo Hong, Hye-Ran Park, Chul-Ho Lee, Yongseok Choi
  • Publication number: 20090182014
    Abstract: The present invention relates to insecticidal compositions comprising compounds having an inhibitory activity versus acyl CoA: cholesterol acyltransferase (ACAT) or salts thereof as effective ingredients. The compounds having inhibitory activity versus ACAT have an excellent insecticidal effect by inhibiting sterol metabolism in noxious insects. Therefore, the compounds of the present invention can be used as safe and effective insecticides.
    Type: Application
    Filed: January 21, 2009
    Publication date: July 16, 2009
    Inventors: YOUNG-KOOK KIM, Hyun-Sun Lee, Mun-Chual Rho, Sung-Uk Kim
  • Publication number: 20080268076
    Abstract: Disclosed herein is a composition having activity of inhibiting acyl-CoA: cholesterol acyltransf erase, which comprises retrofractamide A, pipercide, piperrolein B, piperchabamide D, pellitorin or combinations thereof, or a pharmaceutically acceptable salt thereof . The composition is effective for preventing and treating vascular diseases, such as hyperlipidemia, arteriosclerosis, etc.
    Type: Application
    Filed: July 8, 2005
    Publication date: October 30, 2008
    Inventors: Young kook Kim, Mun chual Rho, Hyun sun Lee, Seung woong Lee, Oh eok Kwon, Mi yeon Chung, Jung ho Choi, Mi sook Dong
  • Publication number: 20060135564
    Abstract: The present invention relates to insecticidal compositions comprising compounds having an inhibitory activity versus acyl CoA:cholesterol acyltransferase (ACAT) or salts thereof as effective ingredients. The compounds having inhibitory activity versus ACAT have an excellent insecticidal effect by inhibiting sterol metabolism in noxious insects. Therefore, the compounds of the present invention can be used as safe and effective insecticides.
    Type: Application
    Filed: December 11, 2003
    Publication date: June 22, 2006
    Inventors: Young-Kook Kim, Hyun-sun Lee, Mun-Chual Rho, Sung-Uk Kim
  • Patent number: 6140363
    Abstract: The present invention relates to use of rosmarinic acid and/or derivatives thereof as immunosuppressive agents and/or as inhibitor of SH2 domain function. Disclosed in the present invention is that rosmarinic acid and derivatives thereof specifically inhibit the binding of ligand peptides to Lck SH2 domain, disturb the Lck-mediated signal transduction in T cells, also inhibit cytoline gene expression, and suppress immune responses in the transplanted tissue. These activities of rosmarinic acid and derivatives thereof support their applicability to treatment, prevention and/or diagnosis of graft rejection, GVHD, autoimmune diseases, inflammatory diseases, etc.
    Type: Grant
    Filed: May 14, 1999
    Date of Patent: October 31, 2000
    Assignee: Mogam Biotechnology Research Institute
    Inventors: Eun Mi Hur, Young Bong Choi, Changwon Park, Jongsung Lee, Dongsu Park, Yungdae Yun, Keun Hyeung Lee, Jong-Eun Oh, Soon Choul Ahn, Hyun Sun Lee, Jong Sok Ahn, Soo Il Jung